CClinicalTrials.gg
CompletedNCT02703818UEPUpdated Dec 3, 2018

SCS for the Treatment Of Chronic Pain of the Upper Extremities

An interventional study of Senza in Upper Extremity Pain, sponsored by Nevro Corp. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2018-12-03.

Sponsored by Nevro Corp · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
64
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

This is a prospective, multi-center post-market study of the Senza System in subjects with chronic, intractable pain of the upper extremities. Data at follow-up visits will be compared to Baseline data collected at the beginning of the study.

02

Conditions studied

  • Upper Extremity Pain

Browse trials for

03

In context

Chronic Pain

2,930 studies on the registry are indexed under Chronic Pain; 701 are open to participants now.

This study's enrollment of 64 is close to the median of 60 across 2,161 interventional studies indexed under Chronic Pain.

Browse Chronic Pain studies →

Lead sponsor

Nevro Corp is the lead sponsor of 10 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Key Inclusion Criteria:

  1. Have been diagnosed with chronic, intractable pain of an upper extremity of neuropathic origin, which has been refractory to conservative therapy for a minimum of 3 months.
  2. Have an average pain intensity (over a period of 7 days) of an upper extremity of ≥ 5 out of 10 cm on the Visual Analog Scale (VAS) at enrollment.
  3. Be on stable pain medications for at least 28 days and be willing to stay on those medications with no dose adjustments until activation of the permanently implanted SCS device.
  4. Be 18 years of age or older at the time of enrollment.
  5. Be an appropriate candidate for the surgical procedures required in this study.
  6. Be capable of subjective evaluation, able to read and understand English-written questionnaires, and are able to read, understand and sign the written inform consent in English.
  7. Have stable neurological status measured by motor, sensory and reflex function.

Key Exclusion Criteria:

  1. Have a medical condition or pain in other area(s), not intended to be treated with SCS, that could interfere with study procedures.
  2. Have a current diagnosis of a progressive neurological disease.
  3. Have a current diagnosis or condition such as a coagulation disorder, bleeding diathesis, platelet dysfunction, progressive peripheral vascular disease or uncontrolled diabetes mellitus that presents excess risk for performing the procedure.
  4. Have mechanical spine instability as determined.
  5. Have significant stenosis, based on MRI.
  6. Have an existing drug pump and/or another active implantable device (switched on or off) such as a pacemaker or other SCS devices.
  7. Have a condition currently requiring or likely to require the use of whole body MRI or diathermy.
  8. Be pregnant (if female and sexually active, subject must be using a reliable form of birth control, be surgically sterile or be at least 2 years post-menopausal).
  9. Have within 6 months of enrollment a significant untreated addiction to dependency producing medications, alcohol or illicit drugs.
  10. Be involved in an injury claim under current litigation.
  11. Have a pending or approved worker's compensation claim.
  12. Have evidence of an active disruptive psychological or psychiatric disorder or other known condition significant enough to impact perception of pain, compliance of intervention and/or ability to evaluate treatment outcome, as determined by a psychologist.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
64 participants (actual)

Study arms

  • Experimental
    Senza

    Spinal Cord Stimulation for UEP

    Device: Senza

Interventions

  • DeviceSenza

    Spinal Cord Stimulation

06

What researchers measure

Primary outcomes

  1. Responder Rate

    Time frame: 3 months

07

Study locations

1 site
  • NEVRO Corp
    Redwood City, California 94065, United States
08

References and documents

Publications

  • Burgher A, Kosek P, Surrett S, Rosen SM, Bromberg T, Gulve A, Kansal A, Wu P, McRoberts WP, Udeshi A, Esposito M, Gliner BE, Maneshi M, Rotte A, Subbaroyan J. Ten kilohertz SCS for Treatment of Chronic Upper Extremity Pain (UEP): Results from Prospective Observational Study. J Pain Res. 2020 Nov 10;13:2837-2851. doi: 10.2147/JPR.S278661. eCollection 2020. PubMed 33204145 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 3, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02703818
Lead sponsor
Nevro Corp
Responsible party
Sponsor
First posted
Mar 9, 2016
Start date
Feb 2016
Primary completion
Aug 2017
Completion
May 2018
Last update
Dec 3, 2018

Study contacts

David Caraway, MD
study director · Nevro Corp

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion